NCT01193244 Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE3
NCT01191931 Prostate HistoScanning for the Non-invasive Detection and Staging of Prostate Cancer and Characterization of Prostate Tissues (PHS-02) Status COMPLETED Phase N/A
NCT01191099 Comprehensive Analysis of Hypoxia in Prostate Cancer: Diagnostic Markers and Prognostic Significance Status UNKNOWN Phase N/A
NCT01188408 Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate Cancer Status WITHDRAWN Phase PHASE2
NCT01188187 Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer Status COMPLETED Phase PHASE3
NCT01187485 A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE1
NCT01177865 Study of Treatment Choice in Patients With Localized Prostate Cancer Status UNKNOWN Phase NA
NCT01176526 The Role of Social Comparisons in Coping and Quality of Life Following a Prostate Cancer Diagnosis Status COMPLETED Phase N/A
NCT01176513 GE-148-002: A Phase 2, Open-label, Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate Cancer Status TERMINATED Phase PHASE2
NCT01174368 Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T Status COMPLETED Phase PHASE2
NCT01174199 Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer Status TERMINATED Phase PHASE1
NCT01174017 Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the Prostate Status COMPLETED Phase PHASE3
NCT01172028 Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01171898 Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC) Status COMPLETED Phase PHASE1/PHASE2
NCT01168479 FLAME: Investigate the Benefit of a Focal Lesion Ablative Microboost in Prostate Cancer Status COMPLETED Phase PHASE3